WEI HU to Uterine Cervical Neoplasms
This is a "connection" page, showing publications WEI HU has written about Uterine Cervical Neoplasms.
Connection Strength
0.196
-
Progressive dysregulation of proliferation during cervical carcinogenesis as measured by MPM-2 antibody staining. Cancer Epidemiol Biomarkers Prev. 1997 Sep; 6(9):711-8.
Score: 0.070
-
Chemotherapy for recurrent and metastatic cervical cancer. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S67-71.
Score: 0.037
-
Cervical chromosome 9 polysomy: validation and use as a surrogate endpoint biomarker in a 4-HPR chemoprevention trial. Gynecol Oncol. 2005 Dec; 99(3 Suppl 1):S32-7.
Score: 0.030
-
Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix. Cancer. 2001 Nov 01; 92(9):2327-33.
Score: 0.023
-
Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial. Clin Cancer Res. 1998 Jun; 4(6):1383-91.
Score: 0.018
-
DNA image cytometric measurement as a surrogate end point biomarker in a phase I trial of alpha-difluoromethylornithine for cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev. 1997 Oct; 6(10):849-55.
Score: 0.018